Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Retatrutide is currently under investigation in a global phase 3 clinical trial programme, following promising results from its phase 2 study (NCT04881760) published in the New England Journal of Medicine in 2023
There are six Mounjaro pen strengths available, from 2.5 mg up to 15 mg
Red flags include severe chest pain, difficulty swallowing, vomiting, or signs of gastrointestinal bleedingall of which require prompt medical evaluation
The survey found that 62 percent of physicians rated these expanded uses as "very" or "extremely" effective
US$ 26.14
US$ 22.90
US$ 26.40
